Literature DB >> 11216700

Clinical presentation of rhabdoid tumors of the kidney.

A M Amar1, G Tomlinson, D M Green, N E Breslow, P A de Alarcon.   

Abstract

PURPOSE: We designed this study to differentiate the clinical presentation, particularly the incidence of hematuria, of a rhabdoid tumor of the kidney (RTK), a rare but highly malignant tumor, from a Wilms tumor. PATIENTS AND METHODS: We reviewed patient flow charts from the National Wilms Tumor Study Group and queried participating hospitals to obtain additional information regarding presenting symptoms and laboratory data for fifty patients. Patient ages ranged from 2 days to 3.5 years with a mean of 11 months. We documented the presence of gross and microscopic hematuria, fever, and hypercalcemia.
RESULTS: Whereas 75% of children with rhabdoid tumor of the kidney (RTK) had stage III (44%), IV (27%), or V (4%) tumors, 67% of children with Wilms tumors had stage I (41%) or II (26%) tumors. Either gross or microscopic hematuria was present in 84.4% (27/32) of the patients with RTK. Gross hematuria was present in 59% (22/37) of children with RTK compared with 18% previously reported with Wilms tumor. Microscopic hematuria was present in 76% (22/29) of children with RTK compared with 24% previously reported with Wilms tumor. Fever was found in 44% (16/36) of children with RTK, compared with 22% of children previously reported with Wilms tumor. Hypercalcemia was seen 26% (6/23) of children with RTK.
CONCLUSION: Although diagnosis of any renal mass still must be confirmed with histopathologic features, a distinct clinical presentation with fever, hematuria, a young age, and high-tumor stage at presentation suggests the diagnosis of RTK.

Entities:  

Mesh:

Year:  2001        PMID: 11216700     DOI: 10.1097/00043426-200102000-00007

Source DB:  PubMed          Journal:  J Pediatr Hematol Oncol        ISSN: 1077-4114            Impact factor:   1.289


  16 in total

1.  Preclinical Evaluation of UAB30 in Pediatric Renal and Hepatic Malignancies.

Authors:  Alicia M Waters; Jerry E Stewart; Venkatram R Atigadda; Elizabeth Mroczek-Musulman; Donald D Muccio; Clinton J Grubbs; Elizabeth A Beierle
Journal:  Mol Cancer Ther       Date:  2016-02-12       Impact factor: 6.261

2.  Primary renal sarcomas in the Intergroup Rhabdomyosarcoma Study Group (IRSG) experience, 1972-2005: A report from the Children's Oncology Group.

Authors:  Beverly Raney; James Anderson; Carola Arndt; Willam Crist; Harold Maurer; Stephen Qualman; Moody Wharam; Eugene Wiener; William Meyer
Journal:  Pediatr Blood Cancer       Date:  2008-09       Impact factor: 3.167

3.  Clinical and Prognostic Characteristics of 53 Cases of Extracranial Malignant Rhabdoid Tumor in Children. A Single-Institute Experience from 2007 to 2017.

Authors:  Haiyan Cheng; Shen Yang; Siyu Cai; Xiaoli Ma; Hong Qin; Weiping Zhang; Libing Fu; Qi Zeng; Mingjie Wen; Xiaoxia Peng; Huanmin Wang
Journal:  Oncologist       Date:  2019-03-26

Review 4.  WARM N COLD: malignant and benign renal tumors in children.

Authors:  Thomas Ray Sanchez; Jonathan Ducore; Jay Balagtas; Christopher Molloy; Sandra L Wootton-Gorges
Journal:  Emerg Radiol       Date:  2014-02-26

Review 5.  Rhabdoid tumor of the kidney with spontaneous rupture: case report and review of literature.

Authors:  Chi-Jen Chang; Ming-Lun Yeh; Cha-Chun Chen
Journal:  Pediatr Surg Int       Date:  2007-05-10       Impact factor: 1.827

6.  A report of renal artery embolization for hematuria facilitating neoadjuvant chemotherapy in an unresectable malignant renal rhabdoid tumor.

Authors:  Ruchika Sharma; Brenda J Kitchen; Rajen Mody; Aghiad Chamdin; Steven Bruch; Rama Jasty
Journal:  Pediatr Surg Int       Date:  2013-01-24       Impact factor: 1.827

Review 7.  The Skin as an Early Expression of Malignancies in the Neonatal Age: A Review of the Literature and a Case Series.

Authors:  Vito Mondì; Fiammetta Piersigilli; Guglielmo Salvatori; Cinzia Auriti
Journal:  Biomed Res Int       Date:  2015-12-21       Impact factor: 3.411

8.  Primary pediatric stage III renal diffuse large B-cell lymphoma.

Authors:  Akira Hayakawa; Nobuya Shimotake; Ikuko Kubokawa; Yoshihiro Mitsuda; Takeshi Mori; Tomoko Yanai; Mototsugu Muramaki; Hideaki Miyake; Masato Fujisawa; Kazumoto Iijima
Journal:  Am J Case Rep       Date:  2013-02-13

9.  Preclinical evaluation of engineered oncolytic herpes simplex virus for the treatment of pediatric solid tumors.

Authors:  Michael L Megison; Lauren A Gillory; Jerry E Stewart; Hugh C Nabers; Elizabeth Mroczek-Musulman; Alicia M Waters; Jennifer M Coleman; Virginia Kelly; James M Markert; G Yancey Gillespie; Gregory K Friedman; Elizabeth A Beierle
Journal:  PLoS One       Date:  2014-01-30       Impact factor: 3.240

10.  Uncommon renal tumors in children: A single center experience.

Authors:  Kartik Chandra Mandal; Madhumita Mukhopadhyay; Shibsankar Barman; Pankaj Halder; Biswanath Mukhopadhyay; Rajarshi Kumar
Journal:  J Indian Assoc Pediatr Surg       Date:  2016 Apr-Jun
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.